LogicBio Therapeutics Inc

LOGC

NASDAQ. Currency in USD

2.07 +0.01 ( +0.49% )

Real time prices: November 15

Market Cap.
68.23M
Beta (5Y monthly)
4.62
Price/Earnings
-
EPS (TTM)
-0.63
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
153,044
1y Target Est.
15.00
Day's Range
2.06
-
2.07
52 Week's Range
0.26
-
2.07

Historical Summary

Performance
EPS growth
Share Buybacks

About LogicBio Therapeutics Inc

Sector
Healthcare
Industry
Biotechnology
Website
https://www.logicbio.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
32.16M
Employees
62
Address
65 Hayden Avenue, Lexington, MA, United States, 02421
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is an adeno-associated virus, which is designed to optimize gene delivery for treatments in a range of indications and tissues. Its lead product candidate is LB-001 that is in Phase I/II clinical trials for the treatment of methylmalonic acidemia. The company has a collaboration with Children's Medical Research Institute to develop next-generation capsids for gene therapy and gene editing applications in the liver, as well as additional tissues; and a collaboration agreement with Takeda Pharmaceutical Company Limited to develop LB-301, an investigational therapy for the treatment of Crigler-Najjar syndrome. The company also has a research collaboration, license, and option agreement with CANbridge Care Pharma Hong Kong Limited; and collaboration agreement with Daiichi Sankyo Company. The company was incorporated in 2014 and is headquartered in Lexington, Massachusetts. As of November 15, 2022, LogicBio Therapeutics, Inc. operates as a subsidiary of Alexion Pharmaceuticals, Inc..

Latest news

Why Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterday
Why Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterday

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday...
By Benzinga - 17 weeks ago

Nasdaq Jumps 270 Points; Silver Surges Over 8%
Nasdaq Jumps 270 Points; Silver Surges Over 8%

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite climbing around...
By Benzinga - 17 weeks ago

Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session
Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) gained 641% to $2.0207 after the company announced it...
By Benzinga - 17 weeks ago

S&P 500 Surges 2%; Crude Oil Rises Sharply
S&P 500 Surges 2%; Crude Oil Rises Sharply

U.S. stocks extended gains midway through trading, with the Dow Jones gaining more than 600...
By Benzinga - 17 weeks ago

The Zacks Analyst Blog highlights Consolidated Water, Ashford Hospitality Trust, BankFinancial, LogicBio Therapeutics and ProPhase Labs
The Zacks Analyst Blog highlights Consolidated Water, Ashford Hospitality Trust, BankFinancial, LogicBio Therapeutics and ProPhase Labs

Consolidated Water, Ashford Hospitality Trust, BankFinancial, LogicBio Therapeutics and ProPhase Labs are part of the...
By Zacks Investment Research - 17 weeks ago

5 Big Winners as Dollar Strengthens on Fed Rate Hike
5 Big Winners as Dollar Strengthens on Fed Rate Hike

A stronger dollar is a boon for Consolidated Water (CWCO), Ashford Hospitality Trust (AHT), BankFinancial...
By Zacks Investment Research - 17 weeks ago

5 Winning Stocks Backed by the Overlooked Trick of Rising P/E
5 Winning Stocks Backed by the Overlooked Trick of Rising P/E

Want to try an out-of-the-box approach? Tap Eastside Distilling (EAST), LogicBio Therapeutics (LOGC), Seabridge Gold...
By Zacks Investment Research - 17 weeks ago

This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday
This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday

Gainers Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule...
By Benzinga - 23 weeks ago